Related Experiment Videos
Autoimmune demyelination in transgenic E alpha d-positive A.CA mice. Comparison with E-negative A.CA mice
A H Cross1, S Ishikawa, C S Raine
1Department of Neurology, Albert Einstein College of Medicine, Bronx, New York.
Summary
The major histocompatibility complex class II E molecule does not appear to induce immune tolerance or suppress autoimmunity, as shown in experimental autoimmune encephalomyelitis studies in transgenic mice. Further research is needed for autoimmune demyelinating disorders.
Area of Science:
- Immunology
- Neuroscience
- Genetics
Background:
- The major histocompatibility complex (MHC) class II E molecule's role in immune tolerance and immunosuppression is debated.
- Experimental autoimmune encephalomyelitis (EAE) is an autoimmune disease dependent on MHC class II molecules.
Purpose of the Study:
- To investigate the role of the MHC class II E molecule in the development of autoimmune diseases.
- To understand the regulatory mechanisms of susceptibility to EAE.
Main Methods:
- EAE was induced in transgenic mice expressing an MHC class II E alpha d-transgene.
- EAE induction was compared between transgenic and non-transgenic mice (E-negative) of the A.CA (H-2f) strain.
- Adoptive transfer methodology was used to induce EAE in both groups.
Main Results:
- EAE was successfully induced in both transgenic and non-transgenic mice.
- No significant differences in disease onset, course, or neuropathology were observed between the groups.
- Non-irradiated transgenic mice showed increased inflammation and demyelination compared to non-transgenic counterparts.
- Histological findings in A.CA mice differed from other susceptible strains, with prominent polymorphonuclear cells and lipid-laden macrophages.
Conclusions:
- The MHC class II E molecule does not appear to be intrinsically involved in inducing tolerance or immunosuppression against autoimmunity.
- Genetic manipulation of the immune system offers a valuable approach for studying autoimmune demyelinating diseases like multiple sclerosis.